Cargando…
WFH State‐of‐the‐art paper 2020: In vivo lentiviral vector gene therapy for haemophilia
Over the last decade, the development of new treatments for haemophilia has progressed at a very rapid pace. Despite all the promising advances in protein products, the prospect offered by gene therapy of a single potentially lifelong treatment remains attractive for people with haemophilia. Transfe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984334/ https://www.ncbi.nlm.nih.gov/pubmed/32537776 http://dx.doi.org/10.1111/hae.14056 |